Fig. 3From: Identification of CEACAM5 as a stemness-related inhibitory immune checkpoint in pancreatic cancerMutual relevance of the inhibitory immune checkpoints in pancreatic cancer. A Profile of Spearman's correlation between the inhibitory immune checkpoints in pancreatic cancer based on the TCGA data. B Profile of Pearson’s correlation between the inhibitory immune checkpoints in pancreatic cancer based on the CTRP data. C The landscape of genetic alterations of the inhibitory immune checkpoints in pancreatic cancer. D-F The levels of (D) CD80, (E) CD86 and (F) AXL expression in pancreatic cancers with high vs. low mRNAsi scoresBack to article page